Aravind Asokan focuses on Genetic enhancement, Virus, Virology, Transduction and Adeno-associated virus. The Genetic enhancement study which covers Gene transfer that intersects with Neuroscience and Central nervous system. His research integrates issues of mdx mouse, Duchenne muscular dystrophy and Dystrophin in his study of Virus.
Aravind Asokan studied Virology and Vector that intersect with Gene delivery and Molecular genetics. The various areas that Aravind Asokan examines in his Transduction study include Molecular biology, Tissue tropism, Glycosylation and Capsid. While the research belongs to areas of Adeno-associated virus, Aravind Asokan spends his time largely on the problem of Tropism, intersecting his research to questions surrounding DNA shuffling and Genome.
His main research concerns Transduction, Capsid, Virology, Genetic enhancement and Cell biology. His work carried out in the field of Transduction brings together such families of science as Tropism, Adeno-associated virus, Viral vector, Recombinant DNA and Molecular biology. His Capsid study is focused on Virus in general.
His biological study deals with issues like In vivo, which deal with fields such as Cell. His studies deal with areas such as Cancer research, Gene expression, Transgene, Central nervous system and Immunology as well as Genetic enhancement. His Cell biology study combines topics in areas such as Genome editing, Aquaporin 4, Glymphatic system and Transcription.
Aravind Asokan mainly investigates Cell biology, Transduction, Genetic enhancement, Virus and Capsid. The Cell biology study combines topics in areas such as CRISPR, Transcription and Gene. His study in Transduction is interdisciplinary in nature, drawing from both Ionomycin, Calcium, Adeno-associated virus and Recombinant DNA.
His Genetic enhancement research incorporates elements of Ataxia, ATP1A3, Bioinformatics and Vector. His study on Virus is covered under Virology. Aravind Asokan combines subjects such as Amino acid, Viral vector and Sequence with his study of Capsid.
The scientist’s investigation covers issues in Recombinant DNA, Capsid, Virus, Transduction and Virology. His study on Recombinant DNA also encompasses disciplines like
His Virus research is multidisciplinary, incorporating perspectives in CRISPR, mdx mouse, Genome, Genetic enhancement and Antibody. His Transduction study combines topics from a wide range of disciplines, such as Transgene, Transfection, Transcription, Gene silencing and Ubiquitin ligase. The concepts of his Virology study are interwoven with issues in Cytoplasm, RNA, Picornaviridae, Endocytosis and Endosome.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.
Christopher E. Nelson;Chady H. Hakim;David G. Ousterout;Pratiksha I. Thakore.
Adeno-associated virus serotypes: vector toolkit for human gene therapy.
Zhijian Wu;Aravind Asokan;R. Jude Samulski.
Molecular Therapy (2006)
The AAV Vector Toolkit: Poised at the Clinical Crossroads
Aravind Asokan;David V Schaffer;David V Schaffer;R Jude Samulski.
Molecular Therapy (2012)
Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles
Wuping Li;Aravind Asokan;Zhijian Wu;Terry Van Dyke.
Molecular Therapy (2008)
Aquaporin-4-dependent glymphatic solute transport in the rodent brain.
Humberto Mestre;Lauren M. Hablitz;Anna L.R. Xavier;Weixi Feng.
Terminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9
Shen Shen;Kelli D. Bryant;Sarah M. Brown;Scott H. Randell.
Journal of Biological Chemistry (2011)
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
Christopher E. Nelson;Yaoying Wu;Matthew P. Gemberling;Matthew L. Oliver.
Nature Medicine (2019)
Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle
Aravind Asokan;Julia C. Conway;Jana L. Phillips;Chengwen Li.
Nature Biotechnology (2010)
Single Amino Acid Changes Can Influence Titer, Heparin Binding, and Tissue Tropism in Different Adeno-Associated Virus Serotypes
Zhijian Wu;Aravind Asokan;Joshua C. Grieger;Lakshmanan Govindasamy.
Journal of Virology (2006)
Adeno-Associated Virus Type 2 Contains an Integrin α5β1 Binding Domain Essential for Viral Cell Entry
Aravind Asokan;Julie B. Hamra;Lakshmanan Govindasamy;Mavis Agbandje-McKenna.
Journal of Virology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: